FMB Wealth Management’s RTX Corp RTX Stock Holding History

FMB Wealth Management’s Portfolio RTX Stock Details RTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,309	Closed	-$240K	–	90
2025 Q4	$240K	Hold	1,309	–	–	0.09%	77
2025 Q3	$219K	Buy	+1,309	New	+$203K	0.09%	81
2023 Q1	–	Sell	-2,035	Closed	-$205K	–	57
2022 Q4	$205K	Buy	+2,035	New	+$191K	0.26%	50

Other funds holding RTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FMB Wealth Management's RTX Position: Q1 2026 in Review

FMB Wealth Management sold out of RTX Corp (RTX) in Q1 2026, closing a stake of 1,309 shares — an estimated $240K sold.

FMB Wealth Management first reported a position in RTX in Q4 2022 and held it in 3 quarters. The position peaked at $240K in Q4 2025. 3,451 funds tracked by Wall St. Rank hold RTX as of Q1 2026.

FMB Wealth Management reported no remaining RTX Corp position as of Q1 2026 after selling out during the quarter.
FMB Wealth Management sold 1,309 RTX Corp shares in Q1 2026, an estimated $240K.
FMB Wealth Management first reported a position in RTX Corp in Q4 2022 and held it in 3 quarters.
FMB Wealth Management's RTX Corp position peaked at $240K in Q4 2025.
3,451 funds tracked by Wall St. Rank held RTX Corp as of Q1 2026.

Based on FMB Wealth Management's 13F filing for Q1 2026, filed 16 Apr 2026.